<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"familial non-medullary thyroid cancer":1,
"family screening":1,
"paediatric":1,
"papillary thyroid cancer":7,
"ultrasound":6,
"differentiated thyroid carcinoma":4,
"lymph node metastasis":4,
"lymph node posterior to right recurrent laryngeal nerve":1,
"3D matrix":1,
"FTC-133 cells":1,
"LRP-1":1,
"collagen type I":1,
"migration":1,
"Cytological sub-categories":1,
"Indeterminate thyroid nodule":2,
"Thyroid nodule clinical risk":1,
"Thyroid nodule management":1,
"navigation program":1,
"perioperative care":1,
"satisfaction":1,
"thyroid cancer":15,
"Classification":1,
"FFPE tissue":1,
"Mass spectrometry imaging":2,
"Molecular signature":1,
"Laser":1,
"Minimally invasive treatment":1,
"Papillary thyroid microcarcinoma":1,
"Thermal ablation":2,
"Bilateral axillo-breast approach":1,
"Firefly technology":1,
"Indocyanine green fluorescence":1,
"Near infrared":1,
"Parathyroid glands":2,
"Robotic thyroidectomy":1,
"DICER1 germline mutation":1,
"DICER1-syndrome":1,
"Embryonal rhabdomyosarcoma":1,
"Focal nodular hyperplasia":1,
"Frameshift":1,
"Medulloepithelioma":1,
"Pleuropulmonary blastoma":1,
"Renal cysts":1,
"BRAF V600E mutation":2,
"Thy3a":1,
"Thy3f":1,
"Thy4":1,
"Cancer":4,
"Proteomics":1,
"Thyroid":14,
"Tissue microarray":1,
"Biopsy, fine-needle":1,
"Biopsy, large-core needle":1,
"Carcinoma, renal cell":1,
"Neoplasm metastasis":1,
"Thyroid gland":2,
"Ultrasonography":6,
"HER2":1,
"Lung adenocarcinoma":1,
"MUC4":1,
"Prognosis":5,
"Smoking status":1,
"Breast cancer":5,
"Clinical trial":1,
"Postoperative radiation therapy":1,
"differentiated thyroid cancer":4,
"dosimetry":1,
"imaging":2,
"radionuclide therapy":1,
"radiopharmaceuticals":1,
"SERCA":1,
"apoptosis":3,
"breast cancer cells":1,
"calcium":1,
"resveratrol":1,
"Family history":1,
"Systemic review":1,
"Endoscopic surveillance":1,
"Familial adenomatous polyposis":1,
"Gastric cancer":2,
"Screening":1,
"annual percent change":1,
"average annual percent change":1,
"early estimates of cancer incidence rates":1,
"population-based registry data":1,
"registry-specific delay-adjustment":1,
"job-exposure matrix":1,
"occupational exposure":1,
"(18)F-FDG PET/CT":1,
"(18)F-FDG PET/TC":1,
"Carcinoma de células escamosas":1,
"Positron emission tomography":2,
"Squamous cell carcinoma":2,
"Tiroides":1,
"Tomografía por emisión de positrones":1,
"Ewing sarcoma":1,
"childhood cancer survivors":1,
"chronic health conditions":1,
"late mortality":1,
"treatment-related complications":1,
"Curcumin":1,
"G2/M arrest":1,
"NF-κB":2,
"Acromegaly":1,
"Inappropriate TSH secretion":1,
"Pituitary tumor":1,
"TSHoma":1,
"Thyroid carcinoma":6,
"CAFs":1,
"Exosomes":1,
"PBX3":1,
"Tumourigenesis":1,
"miR-320a":1,
"Follicular thyroid carcinoma":3,
"Recurrence":4,
"Thyroidectomy":6,
"BRAF mutation":2,
"fluorodeoxyglucose F18":1,
"thyroid neoplasms":2,
"thyroid neoplasm":4,
"genomics":1,
"hereditary endocrine neoplasia":1,
"medullary thyroid cancer":1,
"neoplasia":1,
"paraganglioma":2,
"phaeochromocytoma":1,
"tumour heterogeneity":1,
"Atypical presentation":1,
"Metastasis":3,
"Survival":2,
"Bethesda":1,
"adequacy":1,
"atypia":1,
"fine-needle aspiration":2,
"nondiagnostic":1,
"Computer-assisted":1,
"Diagnosis":3,
"(99m)Tc-MIBI scintigraphy":1,
"Adenoma quístico paratiroideo":1,
"Cystic parathyroid adenoma":1,
"Gammagrafía (99m)Tc-MIBI":1,
"Hiperparatiroidismo primario":1,
"Primary hyperparathyroidism":1,
"head and neck ultrasound":2,
"pitfalls":1,
"sonography":3,
"Follicular variant":1,
"Infiltrative":1,
"Microcalcifications":1,
"Papillary":2,
"head and neck":1,
"Everolimus":1,
"Neuroendocrine tumours":1,
"Therapy":1,
"mTOR inhibitors":1,
"Papillary thyroid carcinoma":17,
"ROLL":1,
"fresh cadaver":1,
"otolaryngology education":1,
"thyroid biopsy":1,
"thyroid mass":1,
"AUS/FLUS":2,
"Bethesda III":1,
"malignancy":1,
"subcategorization":1,
"thyroid nodule":2,
"IL-1β":1,
"inflammation":2,
"non-medullary thyroid cancer":1,
"radioactive iodide therapy":1,
"T cell receptors":1,
"high-throughput sequencing":1,
"multifocal papillary thyroid carcinoma":1,
"neoantigens":1,
"tumour-infiltrating lymphocytes":1,
"Chemoradiation":1,
"Dysphagia":1,
"Prophylactic exercises":1,
"Quality of life":1,
"Swallowing":1,
"external beam radiation therapy":1,
"radioactive iodine":1,
"stage IV":1,
"papillary carcinoma":1,
"recurrence pattern":1,
"relapse":1,
"remission":1,
"central compartment":1,
"elective":1,
"extrathyroidal extension":2,
"lymph node dissection":1,
"lymph node metastases":1,
"papillary thyroid cancer (PTC)":1,
"prophylactic":1,
"therapeutic":1,
"Mucosal melanoma":1,
"Oropharynx":1,
"Palatine tonsil":1,
"Primary tonsillar melanoma":1,
"Tonsillar melanoma":1,
"anaplastic thyroid carcinoma":4,
"clinical trials":1,
"multidisciplinary care":1,
"quality improvement":1,
"radioiodine":1,
"recombinant Human TSH":1,
"salivary":1,
"sialadenitis":1,
"Superb Micro-Vascular Imaging":1,
"vascularity":1,
"active surveillance":1,
"repeated FNA":1,
"surgery":1,
"biopsy/needle aspiration":1,
"cytology":1,
"kinetics":1,
"lung":2,
"response evaluation criteria in solid tumors":1,
"Caspase activation":1,
"Human papillary thyroid cancer":1,
"Myricetin":1,
"anaplastic":1,
"lenvatinib":3,
"treatment":2,
"SEER program":1,
"inflammatory breast cancer":1,
"molecular subtypes":1,
"outcomes":1,
"diagnostic performance":1,
"indeterminate thyroid nodules":2,
"meta-analysis":1,
"systematic review":1,
"thyroid FNA cytology":1,
"Characteristics and pathology of human cancer":1,
"microRNA/non-coding RNA respiratory organ":1,
"oncogenes and tumor-suppressor genes":1,
"Mito-CP":1,
"Mito-Q":1,
"cabozantinib":2,
"drug resistance":1,
"medullary thyroid carcinoma":2,
"mitochondria":1,
"vandetanib":1,
"American Thyroid Association (ATA) guidelines":1,
"epidemiology":2,
"international":1,
"survey":1,
"recurrent laryngeal nerve":1,
"superior parathyroid":1,
"colorectal cancer":1,
"expression":1,
"kidney-type glutaminase (GLS1)":1,
"knockdown":1,
"pyruvate kinase M2 type (PKM2)":1,
"Axillary approach":1,
"Gas inflation":1,
"Single incision endoscopic thyroidectomy":1,
"cancer panel":1,
"fusion gene":1,
"papillary thyroid carcinoma (PTC)":1,
"somatic mutation":1,
"Core needle biopsy":2,
"Fine needle aspiration biopsy":1,
"Hematoma":2,
"good cancer":1,
"patient perspectives":1,
"qualitative research":1,
"Immunotherapy":1,
"Pembrolizumab":1,
"Programmed cell death 1 receptor":1,
"Squamous cell carcinoma of the head and neck":1,
"U S Food and Drug Administration":1,
"PD-1":1,
"immune checkpoint inhibitor":1,
"nivolumab":2,
"painless thyroiditis":1,
"thyrotoxicosis":1,
"Sanger sequencing":1,
"fine needle cytology":1,
"genetic testing":1,
"multiplex PCR":1,
"Cell migration":1,
"Long intergenic noncoding RNA LINC00312":1,
"MicroRNA-197-3p":1,
"invasion and migration":1,
"proliferation":4,
"diffuse large B-cell lymphoma":1,
"incidence":1,
"lymphoma":1,
"second primary malignancy":1,
"biomarkers":1,
"long non-coding RNA":1,
"CEA":1,
"Calcitonin":1,
"Follicular neoplasm":2,
"FoxA1":1,
"BRAF":2,
"Occult primary thyroid carcinoma":1,
"Poorly differentiated thyroid carcinoma":2,
"Epstein-Barr virus":1,
"Polymerase Chain Reaction":1,
"AJCC":1,
"Head and neck cancer":1,
"Stage classification":1,
"TNM":1,
"UICC":1,
"Three Mile Island":1,
"next-generation sequencing":1,
"radiation":1,
"SSTR":1,
"VEGF":1,
"pituicytoma":1,
"targeted therapy":3,
"CRP C-reactive protein":1,
"DII Dietary Inflammatory Index":1,
"ER oestrogen receptor":1,
"PR progesterone receptor":1,
"Case–control studies":1,
"Dietary Inflammatory Index":1,
"A to G mutation":1,
"RAS mutation":1,
"error-prone DNA polymerase":1,
"mutational mechanism":1,
"oxidative stress":1,
"Bim":1,
"biomarker":2,
"luminal A":1,
"microRNA-451":1,
"EPIC":1,
"cohort":1,
"fish":1,
"intake":1,
"High grade":1,
"Meningioma":1,
"Tumor-to-tumor metastasis":1,
"CD20":1,
"pediatrics":1,
"recurrence-free survival":1,
"Atypical histiocytoid cells":1,
"Cyst":1,
"Histiocytes":1,
"Hobnail":1,
"Renal cell":1,
"CABOSUN":1,
"MET":1,
"METEOR":1,
"RCC":1,
"renal cell carcinoma":1,
"Cushing disease":1,
"Cushing syndrome":1,
"adrenal adenoma":1,
"adrenocortical carcinoma":1,
"adrenocorticotropic hormone–independent macronodular adrenal hyperplasia":1,
"pituitary adenoma":1,
"primary pigmented nodular adrenal disease":1,
"EMT":1,
"invasion":2,
"lncRNA TUG1":1,
"miR-145":1,
"clinicopathological characteristics":1,
"pediatric papillary thyroid cancer":1,
"Tenascin-C":1,
"extracellular matrix":1,
"lung cancer":1,
"quantitative proteomics":1,
"tumor microenvironment":1,
"Inhibin beta A":1,
"adjuvant chemotherapy":1,
"Infantile hepatic hemangioendothelioma":1,
"methylprednisolone":1,
"propranolol":1,
"albumin/globulin ratio":1,
"laryngeal squamous cell carcinoma":1,
"prognostic marker":1,
"Radiofrequency ablation":1,
"Technique":1,
"Thyroid nodules":4,
"Goiter":2,
"thyroid-stimulating hormone":1,
"Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography":1,
"renal cell cancer":1,
"tracheal metastasis":1,
"Glucose Tolerance":1,
"Iodine":1,
"Pancreas":1,
"Radioactive":1,
"Sodium-Iodide Symporter":1,
"DEGs":1,
"Enrichment analysis":1,
"Interaction network":1,
"JUN":1,
"PTC":2,
"thyroid autoantibody":1,
"F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography":1,
"I-131 therapy":1,
"lung metastasis":1,
"metabolic tumor volume":1,
"F-18-fludeoxyglucose positron emission tomography/computed tomography":1,
"Ga-68 DOTANOC positron emission tomography/computed tomography":1,
"Hurthle cell neoplasm":1,
"Lu-177 DOTATATE":1,
"peptide receptor radionuclide therapy":1,
"British Thyroid Association 2014 classification":1,
"Clinical evaluation":1,
"Outcome":1,
"Bisphenol A":2,
"endocrine disrupting chemical":1,
"iodine excess intake":1,
"nodular goiter":1,
"elderly":1,
"hypertension":1,
"Overdiagnosis":1,
"Socioeconomic status":1,
"Well-differentiated thyroid cancer":1,
"Hypophysitis":1,
"Immune-related adverse events":1,
"Ipilimumab":1,
"Melanoma":1,
"Thyroiditis":1,
"Berberine":1,
"High glucose":1,
"autophagy":2,
"beclin-1":1,
"microtubule-associated protein 1 light chain 3":1,
"nursing care":1,
"radiotherapy":1,
"vertebral metastases":1,
"Amyotrophic lateral sclerosis":1,
"Brugada syndrome":1,
"Cardiac arrest":1,
"endocrine cancer":1,
"oncology":1,
"thyroid disease":1,
"MAPK":1,
"MMP2":1,
"Trop2":1,
"Mitochondrial ribosomal protein S23":1,
"hepatocellular carcinoma":1,
"Capsule invasion":1,
"Central lymph node dissection":1,
"Central lymph node metastasis":1,
"Solitary papillary thyroid microcarcinomas":1,
"Fourier transform infrared microscopy":1,
"Scintigraphy":1,
"T/B ratio":1,
"Thallium":1,
"GLUT1":1,
"KRAS":1,
"glutathione":1,
"ketogenic diet":1,
"metformin":1,
"vitamin C":1,
"BCPAP":1,
"KI":1,
"YAP":1,
"cell cycle arrest":1,
"immunohistochemistry":3,
"25 OH vitamin D":1,
"ALP":1,
"BMD":1,
"DEXA":1,
"T score":1,
"TSH":2,
"Z score":1,
"corrected calcium":1,
"ionized calcium":1,
"C-reactive protein":1,
"neutrophil-lymphocyte ratio":1,
"platelet-lymphocyte ratio":1,
"Retropharyngeal lymph node":1,
"Transoral surgery":1,
"Autoimmune thyroiditis":1,
"Thyroid cytology":1,
"Fine needle aspiration cytology":1,
"Aberrant thyroid inclusions":1,
"benign epithelial inclusions":1,
"cervical lymph nodes":1,
"metastatic deposits":1,
"EWSR1-ATF1":1,
"Hyalinizing clear cell carcinoma":1,
"Molecular pathology":1,
"Salivary gland tumors":1,
"driver genes":1,
"integrative data":1,
"protein interaction network":1,
"AKT2":1,
"let-7a":1,
"tumor growth":1,
"PCNA":1,
"estrogen receptor α":1,
"iodine excess":1,
"Autoimmunity":1,
"Graves’":1,
"Mean platelet volume":1,
"disease":1,
"National Health Insurance":1,
"Taiwan Cancer Registry":1,
"survival outcome":1,
"fine needle aspiration":1,
"miR-324-5p":1,
"RAI refractory":1,
"sorafenib":1,
"sunitinib":1,
"Magnetic Resonance Imaging":1,
"Ovary":1,
"Teratoma":1,
"Urogenital neoplasms":1,
"Saudi Arabia":1,
"cervical lymph nodal metastasis":1,
"occult primary sites":1,
"carbon nanoparticle":1,
"lymph node excision":1,
"fine needle":1,
"meta analysis":1,
"Carcinoma":1,
"Folliculo-stellate cell":1,
"TTF-1":1,
"pituicyte":1,
"pituitary":1,
"spindle cell oncocytoma":1,
"Thyroid transcription factor-1":1,
"cytokeratin 20":1,
"cytokeratin 5/6":1,
"estrogen receptors":1,
"metastatic lung tumor":1,
"urothelial neoplasm":1,
"Graves’ disease":1,
"Throid hemiagenesis":1,
"Glomus tumors":1,
"complication":1,
"head and neck surgery":1,
"IL-8":1,
"polymorphism":1,
"TCGA":1,
"microRNA-129":1,
"signaling pathways":1,
"target gene":1,
"Hyalinizing trabecular tumor":1,
"N-ras mutation":1,
"thyroid tumor":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2017年7月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
